2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Que Oncology: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor Q-122, Placebo - Vasomotor Symptoms (VMS) | Phase 2 | Completed | Que Oncology | 132 | 2018-10-24 | 2021-07-23 |
| Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen oral capsule of Q-122 - Vasomotor Symptoms (VMS) | Phase 1 | Completed | Que Oncology | 21 | 2014-01-10 | 2020-02-28 |
Breast Neoplasms (1) · Hot Flashes (1)
N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine (2)
Australia (1) · New Zealand (1) · United States (1)
Rob Crombie (1)